Approval · Notice of Compliance 21545 · 2018
SUBLOCADE: Notice of Compliance 21545
Issued November 21, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21545
- Date
- November 21, 2018
- Company
- Indivior Uk LimitedHull, --, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
Products in this notice
Medicinal ingredients
- BUPRENORPHINE 100 MG per 0.5ML
- BUPRENORPHINE 300 MG per 1.5ML